JP2009520772A5 - - Google Patents

Download PDF

Info

Publication number
JP2009520772A5
JP2009520772A5 JP2008546494A JP2008546494A JP2009520772A5 JP 2009520772 A5 JP2009520772 A5 JP 2009520772A5 JP 2008546494 A JP2008546494 A JP 2008546494A JP 2008546494 A JP2008546494 A JP 2008546494A JP 2009520772 A5 JP2009520772 A5 JP 2009520772A5
Authority
JP
Japan
Prior art keywords
hla
seq
pharmaceutical composition
peptide according
chimeric peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008546494A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009520772A (ja
Filing date
Publication date
Priority claimed from ES200503169A external-priority patent/ES2310072B1/es
Application filed filed Critical
Publication of JP2009520772A publication Critical patent/JP2009520772A/ja
Publication of JP2009520772A5 publication Critical patent/JP2009520772A5/ja
Withdrawn legal-status Critical Current

Links

JP2008546494A 2005-12-23 2006-12-19 新規なヘルパーt細胞抗原決定基(thd)ペプチド Withdrawn JP2009520772A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200503169A ES2310072B1 (es) 2005-12-23 2005-12-23 Nuevos peptidos determinantes antigenicos t colaboradores (/dth).
PCT/ES2006/000695 WO2007074188A1 (es) 2005-12-23 2006-12-19 NUEVOS PEPTIDOS DETERMINANTES ANTIGENICOS T COLABORADORES (DTh)

Publications (2)

Publication Number Publication Date
JP2009520772A JP2009520772A (ja) 2009-05-28
JP2009520772A5 true JP2009520772A5 (enExample) 2009-11-26

Family

ID=38217710

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008546494A Withdrawn JP2009520772A (ja) 2005-12-23 2006-12-19 新規なヘルパーt細胞抗原決定基(thd)ペプチド

Country Status (12)

Country Link
US (1) US20090220533A1 (enExample)
EP (1) EP1978026B1 (enExample)
JP (1) JP2009520772A (enExample)
CN (1) CN101374857A (enExample)
AT (1) ATE502047T1 (enExample)
AU (1) AU2006329789A1 (enExample)
BR (1) BRPI0620243A2 (enExample)
CA (1) CA2634840A1 (enExample)
DE (1) DE602006020781D1 (enExample)
ES (1) ES2310072B1 (enExample)
RU (1) RU2008129731A (enExample)
WO (1) WO2007074188A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107375919B (zh) 2009-03-27 2022-07-29 台湾地区“中央研究院” 抗病毒免疫的方法和组合物
TWI537385B (zh) 2010-11-04 2016-06-11 中央研究院 產生具簡單醣基化之表面蛋白質之病毒顆粒的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0735893B1 (en) * 1993-09-14 2008-11-26 Pharmexa Inc. Pan dr-binding peptides for enhancement of the immune response
EP0876398B1 (en) 1996-01-24 2002-07-17 Epimmune, Inc. Induction of immune response against desired determinants
US6413517B1 (en) * 1997-01-23 2002-07-02 Epimmune, Inc. Identification of broadly reactive DR restricted epitopes
CA2332786A1 (en) * 1998-05-29 1999-12-02 Epimmune Inc. Identification of broadly reactive dr restricted epitopes
FR2824326B1 (fr) * 2001-05-04 2004-03-19 Commissariat Energie Atomique Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
US20040236514A1 (en) * 2001-12-13 2004-11-25 Lee Stephen C. Controlling distribution of epitopes in polypeptide sequences

Similar Documents

Publication Publication Date Title
TWI666026B (zh) Wt1抗原胜肽結合疫苗
JP2010536333A5 (enExample)
NO20092774L (no) HLA-A*1101-begrenset WT1-peptid og farmasoytisk preparat som omfatter dette
RU2016101711A (ru) Высокостабильный т-клеточный рецептор и способ его получения и применения
EP2583976A3 (en) Peptide vaccines with SEQ ID NO: 210, 196, 202, 213, 214, 214 or 223 for cancers expressing tumor-associated antigens
CN101522711B (zh) 具有改进性质的重组表面活性剂
JP2018516894A (ja) カッパ(κ)オピオイド受容体(KOR)アゴニストとしての新規の短鎖ペプチド
JP2010110330A5 (enExample)
NZ593833A (en) Extended recombinant polypeptides and compositions comprising same
JP2008536483A5 (enExample)
NO20084008L (no) HLA-A 3303-begrenset WT1-peptid og farmasoytisk preparat omfattende det samme
JP2008530975A5 (enExample)
KR20120115495A (ko) 위장 장애의 치료
HUE032237T2 (en) Treatments for gastrointestinal disorders
CN103415530A (zh) 新型的含有非肽性交联结构的交联肽、以及该交联肽的合成方法和用于该方法的新型有机化合物
HRP20171694T1 (hr) Novi pripravci i postupci
JP2007514752A5 (enExample)
JP2008521795A5 (enExample)
JP2020521784A5 (enExample)
CA2385659A1 (en) Novel antiarrhythmic peptides
JP2009520772A5 (enExample)
EP3868778A3 (en) Cdc45l peptides and vaccines including the same
CA2581110A1 (en) Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions
WO2012155114A1 (en) Peptides derived from uroguanylin and their use in gastrointestinal disorders
JP2012529423A5 (enExample)